Related references
Note: Only part of the references are listed.Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Impact of prior malignancies on outcome of colorectal cancer; revisiting clinical trial eligibility criteria
Muneer J. Al-Husseini et al.
BMC CANCER (2019)
Impact of prior cancer history on the overall survival of patients newly diagnosed with cancer: A pan-cancer analysis of the SEER database
Huaqiang Zhou et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Prevalence of Prior Cancer Among Persons Newly Diagnosed With Cancer An Initial Report From the Surveillance, Epidemiology, and End Results Program
Caitlin C. Murphy et al.
JAMA ONCOLOGY (2018)
Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement
Edward S. Kim et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research Organ Dysfunction, Prior or Concurrent Malignancy, and Comorbidities Working Group
Stuart M. Lichtman et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Re-Evaluating Eligibility Criteria for Oncology Clinical Trials: Analysis of Investigational New Drug Applications in 2015
Susan Jin et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Thoracic Oncology Clinical Trial Eligibility Criteria and Requirements Continue to Increase in Number and Complexity
Sandra Garcia et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Temporal trends in the risk of developing multiple primary cancers: a systematic review
Yuanzi Ye et al.
BMC CANCER (2016)
Anticipating the Silver Tsunami: Prevalence Trajectories and Comorbidity Burden among Older Cancer Survivors in the United States
Shirley M. Bluethmann et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2016)
Exclusion of Gastrointestinal Cancer Patients With Prior Cancer From Clinical Trials: Is This Justified?
Elizabeth C. Smyth et al.
CLINICAL COLORECTAL CANCER (2016)
Effect of Prior Cancer on Outcomes in Advanced Lung Cancer: Implications for Clinical Trial Eligibility and Accrual
Andrew L. Laccetti et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Patterns of Colorectal Cancer Care in the United States: 1990-2010
Caitlin C. Murphy et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Effect of Prior Cancer on Outcomes in Advanced Lung Cancer: Implications for Clinical Trial Eligibility and Accrual
Andrew L. Laccetti et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Patterns of Colorectal Cancer Care in the United States: 1990-2010
Caitlin C. Murphy et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Impact of Prior Cancer on Eligibility for Lung Cancer Clinical Trials
David E. Gerber et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Factors Associated With Use of Preoperative Chemoradiation Therapy for Rectal Cancer in the Cancer Care Outcomes Research and Surveillance Consortium
Mary E. Charlton et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2013)
The effect of multiple primary rules on population-based cancer survival
Hannah K. Weir et al.
CANCER CAUSES & CONTROL (2013)
Identifying Specific Chemotherapeutic Agents in Medicare Data A Validation Study
Jennifer L. Lund et al.
MEDICAL CARE (2013)
Inflation in the number of eligibility criteria for industry-sponsored phase II cancer clinical trial: Illustration over a 20-year period
Stephanie Clisant et al.
CONTEMPORARY CLINICAL TRIALS (2012)
The Utility of the State Buy-In Variable in the Medicare Denominator File to Identify Dually Eligible Medicare-Medicaid Beneficiaries: A Validation Study
Siran M. Koroukian et al.
HEALTH SERVICES RESEARCH (2010)
Multiple cancer prevalence: A growing challenge in long-term survivorship
Angela B. Mariotto et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data
HD Quan et al.
MEDICAL CARE (2005)